Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Kiener Peter A Create: Alert

All | News | Filings
Date FiledTypeDescription
03/27/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/05/2023 4 Kiener Peter A (Director) has filed a Form 4 on Cue Biopharma, Inc.
Txns: Granted 10,000 options to buy @ $2.66, valued at $26.6k
06/24/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/05/2022 4 Kiener Peter A (Director) has filed a Form 4 on Cue Biopharma, Inc.
Txns: Granted 10,000 options to buy @ $12.28, valued at $122.8k
11/17/2021 4 Kiener Peter A (Director) has filed a Form 4 on Cue Biopharma, Inc.
Txns: Sold 18,815 shares @ $17.92, valued at $337.2k
Sold 1,361 shares @ $18.02, valued at $24.5k
Exercised 18,815 options to buy @ $2.86, valued at $53.8k
Exercised 1,361 options to buy @ $2.86, valued at $3.9k
06/29/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/06/2021 4 Kiener Peter A (Director) has filed a Form 4 on Cue Biopharma, Inc.
Txns: Granted 10,000 options to buy @ $12.36, valued at $123.6k
06/25/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/28/2020 4 Kiener Peter A (Director) has filed a Form 4 on PIERIS PHARMACEUTICALS, INC.
Txns: Granted 20,000 options to buy @ $3.23, valued at $64.6k
01/06/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/29/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/03/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/25/2018 4 Kiener Peter A (Director) has filed a Form 4 on PIERIS PHARMACEUTICALS, INC.
Txns: Granted 30,000 options to buy @ $4.46, valued at $133.8k
09/14/2018 3 Kiener Peter A (Director) has filed a Form 3 on PIERIS PHARMACEUTICALS, INC.
06/14/2018 4 Kiener Peter A (Director) has filed a Form 4 on Cue Biopharma, Inc.
Txns: Exercised 9,600 options to buy @ $14.24, valued at $136.7k
02/13/2018 4 Kiener Peter A (Chief Science Officer) has filed a Form 4 on Sucampo Pharmaceuticals, Inc.
Txns: Disposed/sold 44,856 shares @ $18, valued at $807.4k
Disposed/sold 250,000 options to buy @ $8.33, valued at $2.1M
Disposed/sold 38,500 options to buy @ $14.82, valued at $570.6k
Disposed/sold 87,203 options to buy @ $13.8, valued at $1.2M
Disposed/sold 133,000 options to buy @ $11.85, valued at $1.6M
02/13/2018 3/A Kiener Peter A (Director) has filed a Form 3/A on Cue Biopharma, Inc.
01/04/2018 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/02/2018 4 Kiener Peter A (Chief Science Officer) has filed a Form 4 on Sucampo Pharmaceuticals, Inc.
Txns: Paid exercise price by delivering 27,496 shares @ $17.98, valued at $494.4k
12/27/2017 3 Kiener Peter A (Director) has filed a Form 3 on Cue Biopharma, Inc.
12/11/2017 4 Kiener Peter A (Chief Science Officer) has filed a Form 4 on Sucampo Pharmaceuticals, Inc.
Txns: Sold 50,000 shares @ $16.5, valued at $825k
Exercised 50,000 options to buy @ $8.33, valued at $416.5k
07/07/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
05/10/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
03/08/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
01/06/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
07/18/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
06/16/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
03/04/2016 4 Form 4 - Statement of changes in beneficial ownership of securities

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy